Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer

被引：0
|
作者：
R B Egerdie
F Saad
M R Smith
T L J Tammela
J Heracek
P Sieber
C Ke
B Leder
R Dansey
C Goessl
机构：
[1] Urology Associates Urologic Medical Research,Département de Chirurgie
[2] Centre Hospitalier de l’Université de Montréal,Departments of Hematology/Oncology and Medicine
[3] Massachusetts General Hospital Cancer Center,Department of Urology
[4] Tampere University Hospital,undefined
[5] Androgeos,undefined
[6] Urological Associates of Lancaster,undefined
[7] Amgen,undefined
[8] Massachusetts General Hospital Endocrine Unit,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2012年 / 15卷
关键词：
androgen deprivation; bone mineral density; bone loss; antiresorptive therapy; responder analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：308 / 312
页数：4
相关论文
共 50 条
  • [1] A RESPONDER ANALYSIS OF THE EFFECTS OF DENOSUMAB ON BONE MINERAL DENSITY IN MEN WITH PROSTATE CANCER RECEIVING ANDROGEN DEPRIVATION THERAPY
    Egerdie, Blair
    Smith, Matthew R.
    Tammela, Teuvo L. J.
    Saad, Fred
    Ke, Chunlei
    Goessl, Carsten
    Dansey, Roger
    JOURNAL OF UROLOGY, 2009, 181 (04): : 611 - 611
  • [2] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    Egerdie, R. B.
    Saad, F.
    Smith, M. R.
    Tammela, T. L. J.
    Heracek, J.
    Sieber, P.
    Ke, C.
    Leder, B.
    Dansey, R.
    Goessl, C.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (03) : 308 - 312
  • [3] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Saad, Fred
    Egerdie, Blair
    Szwedowski, Maciej
    Tammela, Teuvo L. J.
    Ke, Chunlei
    Leder, Benjamin Z.
    Goessl, Carsten
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2670 - 2675
  • [4] Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer REPLY
    不详
    JOURNAL OF UROLOGY, 2009, 182 (06): : 2676 - 2676
  • [5] Effect of Diphosphonates on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Wu, Congcong
    Chen, Wenjun
    Huang, Xuanzhang
    Lin, Ruifang
    Wu, Jian
    Zhang, Xi
    CLINICAL GENITOURINARY CANCER, 2018, 16 (06) : E1243 - E1250
  • [6] Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer
    Smith, Matthew R.
    Egerdie, Blair
    Toriz, Narciso Hernandez
    Feldman, Robert
    Tammela, Teuvo L. J.
    Saad, Fred
    Heracek, Jiri
    Szwedowski, Maciej
    Ke, Chunlei
    Kupic, Amy
    Leder, Benjamin Z.
    Goessl, Carsten
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 745 - 755
  • [7] Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer
    Morgans, A. K.
    Hancock, M. L.
    Barnette, G.
    Steiner, M. S.
    Morton, R. A.
    Smith, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [8] Racial Differences in Bone Mineral Density and Fractures in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
    Morgans, Alicia K.
    Hancock, Michael L.
    Barnette, K. Gary
    Steiner, Mitchell S.
    Morton, Ronald A.
    Smith, Matthew R.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 889 - 893
  • [9] Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
    Vahakn B. Shahinian
    Yong-Fang Kuo
    Journal of General Internal Medicine, 2013, 28 : 1440 - 1446
  • [10] Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer
    Shahinian, Vahakn B.
    Kuo, Yong-Fang
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (11) : 1440 - 1446
12345